A method refined by Siemens Medical Solutions for assessing a patient's risk for coronary heart disease was presented at the American College of Cardiology meeting. The technique combines use of the Prospective Cardiovascular Muenster Calculator and a
A method refined by Siemens Medical Solutions for assessing a patient's risk for coronary heart disease was presented at the American College of Cardiology meeting. The technique combines use of the Prospective Cardiovascular Muenster Calculator and a multidetector CT examination of the heart to identify individuals at high risk for a future coronary event according to their PROCAM Score. The technique was refined in collaboration with the International Task Force for Prevention of Coronary Heart Disease. The PROCAM Calculator looks at factors that contribute to the risk of heart attack: age, gender, blood lipids, blood pressure, family history, smoking, and diabetes. The score helps quantify risk reduction via lifestyle adjustments and LDL cholesterol-targeted treatment. Multidetector cardiac CT exams visualize constrictions and plaque lesions inside the coronary vessels, potentially allowing for early, targeted treatment of high-risk individuals.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.